Skip to Main Content

Paper Details

Precision medicine at its best: Prolonged survival in a child presenting a secondary mesothelioma treated with crizotinib.
Pediatric Blood and Cancer
2
2021
child, crizotinib, secondary mesothelioma
Author NameAffiliation
Gilles VassalInstitut Gustave Roussy
  • 1 - 1

Datasets

Release 1.2